Nafarelin acetate salt hydrate
CAS 86220-42-0 MFCD00895733
化学结构图
SMILES: O.CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2C=CC=CC=2C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
化学属性
| Mol. Formula | C66H83N17O13· xC2H4O2· yH2O |
|---|---|
| Mol. Weight | 1322.47 (anhydrous free base basis) |
别名和识别编码
| Chemical Name | Nafarelin acetate salt hydrate |
|---|---|
| Synonym | 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate salt hydrate Nafarelin acetate salt hydrate |
| MDL Number | MFCD00895733 |
| CAS Number | 86220-42-0 |
| PubChem Substance ID | 329818673 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, LH-RH, N, Neuropeptides, Peptides and Proteins, Peptides for Cell Biology, Pfizer Compounds, Releasing Factors
- {SNA} Approved Therapeutics/Drug Candidates,
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Fluorination Ready Pharma-Developed Compounds, LH-RH, N, Neuropeptides, Peptides and Proteins, Peptides for Cell Biology, Pfizer Compounds, Releasing Factors, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
相关文献及参考
- Valle, R.F. and Sciarra, J.J., Endometriosis: treatment strategies. Ann. N.Y. Acad. Sci. 997 , 229-239, (2003) 摘要
- Suh, J., et al., Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle. Eur. J. Obstet. Gyn. Rep. Biol. 112 , 64-68, (2004)
- Merck 14 ,6351
京ICP备2020036287号